Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction or Discontinuation of Calcineurine Inhibitors With Conversion to Everolimus-Based Immunosuppresion to Alleviate Chronic Allograft Nephropathy (CAN) in Kidney Transplant Recipients: A Prospective Randomized Study

NCT00443508 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT00443508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00443508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction or Discontinuation of Calcineurine Inhibitors With Conversion to Everolimus-Based Immunosuppresion to Alleviate Chronic Allograft Nephropathy (CAN) in Kidney Transplant Recipients: A Prospective Randomized Study
Lead sponsor
Rabin Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2007
Completion date
February 28, 2010
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases